Adjuvant S-1 Versus Gemcitabine for Node-Positive Perihilar Cholangiocarcinoma:
- This topic has 0 replies, 1 voice, and was last updated 2 years, 10 months ago by
.
Viewing 1 post (of 1 total)
-
Posts
-
Adjuvant S-1 Versus Gemcitabine for Node-Positive Perihilar Cholangiocarcinoma: A Propensity Score-Adjusted Analysis
https://pubmed.ncbi.nlm.nih.gov/34087061/
Viewing 1 post (of 1 total)
- The forum ‘Chemotherapy & More’ is closed to new topics and replies.